Newsletters - MAR 2007

NutraCon 2007: Sabinsa President Discusses Intellectual Property Issues

Todd Norton, president and chief operating officer of Sabinsa Corporation participated in a panel discussion entitled "Creating an Intellectual Property Platform," as part of the Nutracon Conference. Other panel members included Roger Wyse, managing partner, Burrill & Company; Marina Volin, a registered patent attorney with Caesar, Rivise, Bernstein, Cohen and Pokotilow, Ltd.; and Qi Jia, Ph.D., chief science officer, Unigen Pharmaceuticals.

The panel examined the scope of intellectual property issues globally and provided perspectives from both inside and outside the industry. Todd Norton specifically highlighted the value of intellectual property including branding opportunities and return on investment, as well as discussed the realities of promoting and protecting intellectual property in the natural products industry.

 

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.